MSTN and atherosclerosis: Hence, it is not clear whether the associated metabolic phenotype, i.e. strong protection against diet-induced insulin resistance, hepatosteatosis, and atherosclerosis [1]–[3], [5], is directly related to myostatin signaling or secondary to the extreme muscle hypertrophy.